Triple targeting of STING, TGF-β, and PD-L1 boosts CXCL16–CXCR6 signaling for potent antitumor response

Journal:

Nature Communications

Published:

2026-02-09

DOI:

10.1038/s41467-026-69456-3

Affiliations:

8

Authors:

19

Go to article

Institutions	Authors	Share
The First Affiliated Hospital, Zhejiang University School of Medicine, China	8.000000	0.42
Tongji Hospital (TJH), HUST, China	3.333333	0.18
YZYBIO, China	3.000000	0.16
MOE Key Laboratory of Biomass Chemical Engineering, ZJU, China	2.000000	0.11
The Second Affiliated Hospital, Zhejiang University School of Medicine, China	1.000000	0.05
Shanxi Bethune Hospital, China	0.833333	0.04
Shanxi Medical University (SXMU), China	0.833333	0.04

Interested in Immunology?